Acquiring Company
Cencora
Acquired Company
COR
Conshohocken
GermanyBiotechnologyHealth CarePharmaceuticalBiotechnologyHealth CareConsultingDescription
Cencora continues to integrate its acquisition of COR clinical services while enhancing its pharmaceutical distribution capabilities. This acquisition supports Cencora's strategy to provide comprehensive patient-centric solutions and expand its role in clinical services. The company underscores the significance of data-driven logistics and tailored supportive infrastructure in the evolving healthcare landscape.
Quick answer
Cencora is acquiring COR, announced June 29, 2026. Cencora is based in Conshohocken, Pennsylvania, United States.
- How much did Cencora pay for COR?
- The deal value was not disclosed.
- What does Cencora do?
- Cencora is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world.
- Where are Cencora and COR based?
- Cencora is based in Conshohocken, Pennsylvania, United States. COR is based in Germany.
- Who are the decision-makers at Cencora?
- Fundz holds 1 contact at Cencora. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Pharmaceutical and Consulting
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Tarsus Pharmaceuticals to acquire Alkeus Pharmaceuticals (August 6, 2026)
- Supernus to merge with Indivior Pharmaceuticals (August 3, 2026)
- CNR Research acquires EPSI Korea for expansion (July 13, 2026)
- Tarsus acquires iRenix Medical for IRX-101 development (July 8, 2026)
- Jagsonpal Pharmaceuticals acquires Aequitas Healthcare (June 30, 2026)
- GSK to acquire Nuvalent for $10.6 billion, $11B (June 9, 2026)
Who to call at Cencora, and when
When Cencora changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Cencora raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Cencora, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cencora. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Cencora makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired COR?
COR was acquired by Cencora, based in Conshohocken. The deal was reported on June 29, 2026. Cencora is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. Cencora is publicly traded (COR) and operates in Biotechnology.
When did Cencora acquire COR?
Cencora's acquisition of COR was reported on June 29, 2026. Cencora continues to integrate its acquisition of COR clinical services while enhancing its pharmaceutical distribution capabilities. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does COR do?
COR provides clinical services and consulting activities, supporting trial logistics and patient engagement. It is integrated into Cencora's broader manufacturer solutions, enhancing operational support for clinical programs and post-approval services. It is privately held, operating in Biotechnology, and is based in Germany.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.